CatalystPit

ACHVACHIEVE LIFE SCIENCES, INC.

NASDAQ · In Vitro & In Vivo Diagnostic Substances
Last close $7.53 · 2026-10-01
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryIn Vitro & In Vivo Diagnostic Substances
Market cap$832.48M
RECENT INSIDER TRADES
  • 2026-08-21 · Stewart Richard Alistair (Director) · SELL
  • 2025-09-22 · Stewart Richard Alistair (Chief Executive Officer) · SELL
  • 2025-09-22 · Oki Mark K (Chief Financial Officer) · SELL
  • 2025-09-08 · Xinos Jaime (Chief Commercial Officer) · SELL
  • 2025-09-08 · JACOBS CINDY (President & CMO) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders121
Shares held87,401,015
Value$561.76M
Percent of shares outstanding84.94%
As of quarter end2026-06-30
RECENT NEWS
  • Achieve Life Sciences appoints Kaitlyn Tuson as SVP marketing and communications
  • Achieve Life Sciences Announces Granting of New Hire Inducement Awards
  • Achieve Life Sciences appoints new CFO
  • Achieve Life Sciences appoints new CFO
  • Stifel initiates Achieve Life Sciences stock with buy rating
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
ACHIEVE LIFE SCIENCES, INC. (ACHV) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit